Australia Genome Editing Market Size & Outlook, 2024-2030
Australia genome editing market, 2018-2030 (US$M)
Related Markets
Australia genome editing market highlights
- The Australia genome editing market generated a revenue of USD 164.1 million in 2023 and is expected to reach USD 595.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 20.2% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 164.1 million |
| Market revenue in 2030 | USD 595.5 million |
| Growth rate | 20.2% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 2.1% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China genome editing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 626.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 46.56% in 2024. Horizon Databook has segmented the Australia genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing investments by the Thai government, along with the growing market, are responsible for the country becoming a hub for precision medicine and genomic projects. Some of the projects undertaken by the Thailand government are Genomics Thailand Initiative launched in 2019, National Biobank of Thailand (NBT) established in 2019, and the Southeast Asian genome-sequencing project.
Over the past few years, the CDC and Ministry of Public Health in Thailand have been working on developing intervention strategies to fight against high-risk diseases. The prevalence of cancer has increased in the country, accounting for 19% of the overall deaths, followed by 12% of deaths due to ischemic heart disease and 10% due to stroke.
Moreover, an increase in the incidence of infectious diseases such as hepatitis, diarrhea, dengue fever, malaria, Japanese encephalitis, HIV, leptospirosis, and rabies is expected to fuel the demand for genome editing technologies for proper diagnosis & treatment development.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia genome editing market size, by technology, 2018-2030 (US$M)
Australia Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
